Fielmann Aktiengesellschaft - Asset Resilience Ratio
Fielmann Aktiengesellschaft (FIE) has an Asset Resilience Ratio of 12.02% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Fielmann Aktiengesellschaft strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2010–2025)
This chart shows how Fielmann Aktiengesellschaft's Asset Resilience Ratio has changed over time. See FIE equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Fielmann Aktiengesellschaft's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Fielmann Aktiengesellschaft (FIE) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €193.22 Million | 8.09% |
| Short-term Investments | €93.81 Million | 3.93% |
| Total Liquid Assets | €287.03 Million | 12.02% |
Asset Resilience Insights
- Moderate Liquidity: Fielmann Aktiengesellschaft has 12.02% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Fielmann Aktiengesellschaft Industry Peers by Asset Resilience Ratio
Compare Fielmann Aktiengesellschaft's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
West Pharmaceutical Services Inc
NYSE:WST |
Medical Instruments & Supplies | 18.53% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Safe Orthopaedics SA
PA:ALSAF |
Medical Instruments & Supplies | 2.20% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for Fielmann Aktiengesellschaft (2010–2025)
The table below shows the annual Asset Resilience Ratio data for Fielmann Aktiengesellschaft.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.17% | €4.40 Million ≈ $5.14 Million |
€2.66 Billion ≈ $3.12 Billion |
-0.15pp |
| 2024-12-31 | 0.31% | €7.39 Million ≈ $8.64 Million |
€2.37 Billion ≈ $2.77 Billion |
-0.84pp |
| 2023-12-31 | 1.15% | €22.91 Million ≈ $26.78 Million |
€1.99 Billion ≈ $2.32 Billion |
-4.43pp |
| 2022-12-31 | 5.59% | €98.62 Million ≈ $115.29 Million |
€1.77 Billion ≈ $2.06 Billion |
+2.09pp |
| 2021-12-31 | 3.49% | €60.65 Million ≈ $70.90 Million |
€1.74 Billion ≈ $2.03 Billion |
-3.55pp |
| 2020-12-31 | 7.04% | €117.52 Million ≈ $137.39 Million |
€1.67 Billion ≈ $1.95 Billion |
-0.70pp |
| 2019-12-31 | 7.74% | €105.84 Million ≈ $123.73 Million |
€1.37 Billion ≈ $1.60 Billion |
-3.88pp |
| 2018-12-31 | 11.62% | €109.80 Million ≈ $128.37 Million |
€944.79 Million ≈ $1.10 Billion |
-1.06pp |
| 2017-12-31 | 12.68% | €117.40 Million ≈ $137.25 Million |
€925.68 Million ≈ $1.08 Billion |
-5.46pp |
| 2016-12-31 | 18.15% | €165.76 Million ≈ $193.80 Million |
€913.53 Million ≈ $1.07 Billion |
-4.50pp |
| 2015-12-31 | 22.64% | €201.76 Million ≈ $235.88 Million |
€891.11 Million ≈ $1.04 Billion |
+3.63pp |
| 2014-12-31 | 19.01% | €159.20 Million ≈ $186.13 Million |
€837.31 Million ≈ $978.91 Million |
-1.53pp |
| 2013-12-31 | 20.55% | €164.25 Million ≈ $192.02 Million |
€799.43 Million ≈ $934.62 Million |
+19.61pp |
| 2012-12-31 | 0.94% | €7.05 Million ≈ $8.24 Million |
€753.23 Million ≈ $880.60 Million |
-8.10pp |
| 2011-12-31 | 9.03% | €65.68 Million ≈ $76.79 Million |
€727.21 Million ≈ $850.18 Million |
-1.69pp |
| 2010-12-31 | 10.72% | €73.97 Million ≈ $86.48 Million |
€690.11 Million ≈ $806.81 Million |
-- |
About Fielmann Aktiengesellschaft
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, ready-made reading glasses, hearing systems and its accessories, as well as personal protective equipment. It also offers its products under… Read more